Correction: Durable Therapeutic Efficacy Utilizing Combinatorial Blockade Against IDO, CTLA-4, and PD-L1 in Mice With Brain Tumors

Clinical Cancer Research- United States

doi 10.1158/1078-0432.ccr-14-3211

Full Text

Abstract

Available in

Date

Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Rational Combination of Oncolytic Vaccinia Virus and PD-L1 Blockade Works Synergistically to Enhance Therapeutic Efficacy

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Dual Blockade of PD-1 and CTLA-4 Combined With Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors—Response

Cancer Research
Cancer ResearchOncology
2014English

Tumor Vaccines Expressing Flt3 Ligand Synergize With CTLA-4 Blockade to Reject Preimplanted Tumors

Cancer Research
Cancer ResearchOncology
2009English

Oncolytic Virus and PD-1/PD-L1 Blockade Combination Therapy

Oncolytic Virotherapy
2018English

Therapeutic Blockade of PD-L1 and LAG-3 Rapidly Clears Established Blood-Stage Plasmodium Infection

Nature Immunology
AllergyImmunology
2011English

PD-L1 Expression in Inflammatory Myofibroblastic Tumors

Modern Pathology
Forensic MedicinePathology
2018English

CTLA-4 Blockade Plus Adoptive T-Cell Transfer Promotes Optimal Melanoma Immunity in Mice

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2015English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection

OncoImmunology
OncologyAllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy